Accession Number: | 0001209191-21-026162 |
Date: | 2021-04-06 |
Issuer: | AMICUS THERAPEUTICS, INC. (FOLD) |
Original Submission Date: |
CAMPBELL BRADLEY L
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET
PHILADELPHIA, PA 19104
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-04-06 | A | 33,165 | a | $0.00 | 412,022 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | granted in the form of restricted stock units for the achievement of the 2019 prsu revenue goal. each restricted stock unit represents a contingent right to receive one share of amicus common stock. the restricted stock units will vest on december 31, 2021, subject to the reporting person's continued service with the company. |